Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.
The main criterion for treatment effectiveness in Chagas Disease has been the seronegative conversion, achieved many years post-treatment. One of the main limitations in evaluating treatment for chronic Chagas disease is the lack of reliable tests to ensure parasite clearance and to examine the effe...
Saved in:
Main Authors: | Rodolfo Viotti (Author), Carlos Vigliano (Author), María Gabriela Alvarez (Author), Bruno Lococo (Author), Marcos Petti (Author), Graciela Bertocchi (Author), Alejandro Armenti (Author), Ana María De Rissio (Author), Gretchen Cooley (Author), Rick Tarleton (Author), Susana Laucella (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
by: María G Alvarez, et al.
Published: (2016) -
Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy.
by: Damián E Pérez-Mazliah, et al.
Published: (2018) -
Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro.
by: María Ailén Natale, et al.
Published: (2021) -
Chagas disease and the london declaration on neglected tropical diseases.
by: Rick L Tarleton, et al.
Published: (2014) -
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease.
by: Elodie Granjon, et al.
Published: (2016)